Increased funding for cancer drugs

In the recent election, Greg Selinger made the ridiculous suggestion that Brian Pallister might cut funding for cancer drugs. This week that was confirmed to be a total lie.

In reality, Budget 2016 includes an additional $4 million in funding to support the provision of cancer drugs for patients across the province.

“The national work to ensure affordability is significant because there are many new drugs being developed and it is anticipated that cancer drug costs will continue to rise,” said Brian. “We are committed to working with other stakeholders to look at ways to strengthen our system and improve the affordability, accessibility, appropriate prescribing and use of prescription drugs, both across the country and here at home.”

The Provincial Oncology Drug Program includes funding for all intravenous drugs provided for cancer patients provincewide. Manitoba’s Home Cancer Drug Program provides cost-free access to approved oral cancer medications and cancer support drugs including anti-nausea medications that counter side-effects of chemotherapy.

This additional funding will bring the budgeted amount for providing intravenous cancer drugs to approximately $50 million annually.

For more information on cancer drug coverage, visit www.cancercare.mb.ca.